BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · IEX Real-Time Price · USD
5.63
+0.07 (1.26%)
May 2, 2024, 2:37 PM EDT - Market open
BrainsWay Revenue
In the year 2023, BrainsWay had annual revenue of $31.79M with 16.96% growth. Revenue in the quarter ending December 31, 2023 was $9.03M with 49.66% year-over-year growth.
Revenue (ttm)
$31.79M
Revenue Growth
+16.96%
P/S Ratio
2.92
Revenue / Employee
$237,201
Employees
134
Market Cap
94.16M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 30, 2019 | 23.10M | 6.70M | 40.89% |
| Dec 31, 2018 | 16.40M | 5.25M | 47.12% |
| Dec 31, 2017 | 11.15M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Oncology Institute | 324.24M |
| Assertio Holdings | 152.07M |
| Burning Rock Biotech | 75.80M |
| ProPhase Labs | 44.38M |
| Affimed | 9.19M |
| Chimerix | 324.00K |
BWAY News
- 8 days ago - BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 4 weeks ago - BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease - GlobeNewsWire
- 6 weeks ago - BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems - GlobeNewsWire
- 2 months ago - BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights - GlobeNewsWire
- 2 months ago - BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024 - GlobeNewsWire
- 4 months ago - BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology - GlobeNewsWire
- 4 months ago - BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network - GlobeNewsWire
- 5 months ago - BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea - GlobeNewsWire